VSTM
Verastem Inc
NASDAQ · Biotechnology
$6.67
+0.39 (+6.21%)
Open$6.36
Previous Close$6.28
Day High$6.76
Day Low$6.36
52W High$11.25
52W Low$4.01
Volume—
Avg Volume1.70M
Market Cap497.33M
P/E Ratio—
EPS$-3.06
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+110.6% upside
Current
$6.67
$6.67
Target
$14.05
$14.05
$11.84
$14.05 avg
$17.49
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 20.88M | 12.31M | 321.49M |
| Net Income | -272,747,664 | -144,736,378 | 10.36M |
| Profit Margin | -1,306.4% | -1,241.1% | 3.2% |
| EBITDA | -271,442,830 | -152,046,396 | 16.17M |
| Free Cash Flow | — | — | 7.86M |
| Rev Growth | +69.6% | +69.6% | +4.8% |
| Debt/Equity | 0.51 | 0.51 | 0.77 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |